Solu-medrol and Pradaxa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Solu-medrol (methylprednisolone sodium succinate) and Pradaxa (dabigatran etexilate mesylate). Common drug interactions include convulsion among females and hypertension among males.

The phase IV clinical study analyzes what interactions people have when they take Solu-medrol and Pradaxa. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Solu-medrol?

Solu-medrol has active ingredients of methylprednisolone sodium succinate. It is often used in multiple sclerosis. eHealthMe is studying from 39,410 Solu-medrol users. Check the latest studies of Solu-medrol.

What is Pradaxa?

Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 86,906 Pradaxa users. Check the latest studies of Pradaxa.



On Jul, 12, 2026

38 people who take Solu-medrol and Pradaxa together, and have interactions are studied.

Solu-medrol and Pradaxa drug interactions.

What are the common drug interactions of Solu-Medrol and Pradaxa, by gender? *:

female:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  3. Diarrhoea
  4. Dizziness
  5. Drug dependence
  6. Drug ineffective
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  9. Feeling hot
  10. Haemoglobin decreased

male:

  1. Hypertension (high blood pressure)
  2. Asthenia (weakness)
  3. Haematocrit decreased
  4. Haemoglobin decreased
  5. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  6. Intervertebral disc degeneration (spinal disc degeneration)
  7. Intervertebral disc protrusion (spinal disc protrusion)
  8. Lymphocyte count decreased
  9. Mean cell haemoglobin concentration increased (more concentration of haemoglobin in a given volume of packed red blood cells)
  10. Mean cell volume increased (more than normal average red blood cell volume)

What are the common drug interactions of Solu-Medrol and Pradaxa, by age (0-1 to 60+)? *:

0-1:

  1. Acute respiratory failure
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Drug dependence
  4. Pulmonary alveolar haemorrhage (acute bleeding)
  5. Renal failure acute (rapid kidney dysfunction)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chest discomfort
  2. Dyspnoea (difficult or laboured respiration)
  3. Pain in extremity
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Throat irritation
  6. Thrombosis (formation of a blood clot inside a blood vessel)

50-59:

  1. Tremor (trembling or shaking movements in one or more parts of your body)
  2. Visual impairment
  3. Arthropathy
  4. Asthenia (weakness)
  5. Brachial plexopathy (pain, decreased movement, or decreased sensation in the arm and shoulder due to a nerve problem)
  6. Cellulitis (infection under the skin)
  7. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  8. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  9. Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
  10. Eosinophil count decreased

60+:

  1. Hypertension (high blood pressure)
  2. Hyperthermia (body temperature greatly above normal)
  3. Addison's disease (addison's disease, a hormonal disorder disease)
  4. Asthenia (weakness)
  5. Blood pressure decreased
  6. Blood pressure fluctuation
  7. Body temperature fluctuation
  8. Bradycardia (abnormally slow heart action)
  9. Cardiac failure congestive
  10. Endotracheal intubation complication

What are the existing conditions these people have? *

  1. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 7 people, 18.42%
  2. Pain: 5 people, 13.16%
  3. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 4 people, 10.53%
  4. Stress And Anxiety: 3 people, 7.89%
  5. Depression: 3 people, 7.89%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.26%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 5.26%
  8. Hypoglycemia (low blood sugar): 2 people, 5.26%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.26%
  10. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Solu-medrol and Pradaxa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Solu-medrol and Pradaxa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Solu-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pradaxa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Solu-medrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pradaxa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone sodium succinate and dabigatran etexilate mesylate (the active ingredients of Solu-medrol and Pradaxa, respectively), and Solu-medrol and Pradaxa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: